Great Point Partners as of Sept. 30, 2013
Portfolio Holdings for Great Point Partners
Great Point Partners holds 32 positions in its portfolio as reported in the September 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Hyperion Therapeutics | 14.9 | $22M | 821k | 26.13 | |
| Furiex Pharmaceuticals | 10.7 | $15M | 349k | 43.99 | |
| Ambit Bioscience | 9.5 | $14M | 884k | 15.50 | |
| Sunshine Heart | 8.7 | $13M | 1.1M | 11.58 | |
| Geron Corporation (GERN) | 5.8 | $8.3M | 2.5M | 3.35 | |
| Pain Therapeutics | 5.5 | $7.9M | 2.9M | 2.72 | |
| Gentium S.p.A. | 4.2 | $6.1M | 225k | 27.13 | |
| Sophiris Bio | 4.2 | $6.0M | 1.3M | 4.68 | |
| Nanosphere | 3.5 | $5.0M | 2.5M | 2.00 | |
| Durata Therapeutics | 3.2 | $4.6M | 509k | 9.04 | |
| HeartWare International | 3.0 | $4.4M | 60k | 73.20 | |
| Biodel | 2.9 | $4.2M | 1.3M | 3.15 | |
| Trinity Biotech | 2.9 | $4.1M | 189k | 21.76 | |
| Streamline Health Solutions (STRM) | 2.5 | $3.6M | 476k | 7.60 | |
| Volcano Corporation | 2.4 | $3.4M | 143k | 23.95 | |
| Amarin Corporation | 2.2 | $3.2M | 500k | 6.32 | |
| Nordion | 1.8 | $2.6M | 300k | 8.63 | |
| OncoGenex Pharmaceuticals | 1.7 | $2.5M | 265k | 9.27 | |
| Mast Therapeutics | 1.7 | $2.4M | 5.4M | 0.44 | |
| Given Imaging | 1.6 | $2.3M | 118k | 19.23 | |
| RTI Biologics | 1.6 | $2.3M | 606k | 3.74 | |
| Protalix BioTherapeutics | 1.2 | $1.8M | 399k | 4.53 | |
| Mei Pharma | 1.2 | $1.8M | 158k | 11.25 | |
| Therapeuticsmd | 0.8 | $1.2M | 417k | 2.93 | |
| ArQule | 0.6 | $871k | 374k | 2.33 | |
| AVANIR Pharmaceuticals | 0.6 | $846k | 200k | 4.23 | |
| Pernix Therapeutics Holdings | 0.6 | $807k | 297k | 2.72 | |
| D Horizon Pharma | 0.2 | $335k | 100k | 3.35 | |
| Alimera Sciences Comstkusd0.01 | 0.2 | $279k | 74k | 3.76 | |
| Palatin Technologies | 0.1 | $133k | 193k | 0.69 | |
| GTx | 0.1 | $117k | 58k | 2.03 | |
| Wright Med Group Inc right 03/01/2019 | 0.0 | $41k | 117k | 0.35 |
